|
業務類別
|
Drug Manufacturers - General |
|
業務概覽
|
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments. |
| 公司地址
| 30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302 |
| 電話號碼
| +1 551 430-6900 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.organon.com |
| 員工數量
| 10000 |
| Mr. Daniel Karp |
Executive Vice President, Corporate Development and Chief Strategy Officer |
-- |
24/04/2026 |
| Mr. Matthew M. Walsh |
Executive Vice President, Chief Financial Officer and Principal Accounting Officer |
美元 919.23K |
24/04/2026 |
| Ms. Juliana Papa Drinane |
Interim Head of Manufacturing and Supply |
-- |
24/04/2026 |
| Mr. Vittorio Nisita |
Executive Vice President and Head of Enterprise Services and Solutions |
-- |
24/04/2026 |
| Mr. Joseph T. Morrissey, Jr |
Interim Chief Executive Officer |
美元 123 |
24/04/2026 |
| Mr. Kirke Weaver |
Executive Vice President, General Counsel and Corporate Secretary |
美元 676.92K |
24/04/2026 |
| Mr. Aaron Falcione |
Executive Vice President and Chief Human Resources Officer |
-- |
24/04/2026 |
| Ms. Rachel A. Stahler |
Executive Vice President and Chief Digital and Growth Officer |
美元 706.92K |
24/04/2026 |
| Dr. Juan Camilo Arjona Ferreira, M.D. |
Executive Vice President, Head of Research and Development and Chief Medical Officer |
美元 734.62K |
24/04/2026 |
|
|
| Dr. Helene D. Gayle, M.D. |
Independent Director |
24/04/2026 |
| Ms. Shalini Sharp |
Independent Director |
24/04/2026 |
| Mr. Robert A. Essner |
Lead Independent Director |
24/04/2026 |
| Ms. Rochelle B. Lazarus |
Independent Director |
24/04/2026 |
| Ms. Ramona A. Sequeira |
Independent Director |
24/04/2026 |
| Ms. Carrie S. Cox |
Executive Chairman of the Board |
24/04/2026 |
| Dr. Philip Ozuah, M.D.,PhD |
Independent Director |
24/04/2026 |
| Ms. Deborah R. Leone |
Independent Director |
24/04/2026 |
| Dr. Alan Ezekowitz, M.D.,PhD |
Independent Director |
24/04/2026 |
| Ms. Grace Puma |
Independent Director |
24/04/2026 |
| Ms. Cynthia M. Patton |
Independent Director |
24/04/2026 |
|
|
|
|
